Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
164M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
52.6M
-
Shares change
-
+8.8M
-
Total reported value, excl. options
-
$724M
-
Value change
-
+$113M
-
Put/Call ratio
-
5.82
-
Number of buys
-
50
-
Number of sells
-
-28
-
Price
-
$13.75
Significant Holders of Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value (NMRA) as of Q1 2024
99 filings reported holding NMRA - Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value as of Q1 2024.
Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value (NMRA) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.6M shares
of 164M outstanding shares and own 32.05% of the company stock.
Largest 10 shareholders include SOFTBANK GROUP CORP. (7.65M shares), FMR LLC (7.48M shares), MIC Capital Management UK LLP (4.46M shares), T. Rowe Price Investment Management, Inc. (3.58M shares), ICONIQ Capital, LLC (3.4M shares), WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST (3.31M shares), Artal Group S.A. (2.92M shares), EcoR1 Capital, LLC (2.07M shares), JOHNSON & JOHNSON (1.85M shares), and CITADEL ADVISORS LLC (1.82M shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.